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Background: Tuberculosis (TB) remains a significant public health problem leading to high morbidity and mortality
both in adults and children. Reports on childhood TB and its treatment outcome are limited. In this retrospective
study, we analyzed the epidemiology and treatment outcomes of TB among children in Addis Ababa.
Methods: Children registered for TB treatment over 5 years (2007 to 2011) were included in the analysis.
Demographic and clinical data including treatment outcomes were extracted from TB unit registers of 23 health
centers in Addis Ababa. Multivariate logistic regression was used to identify predictors of poor treatment outcomes.
Results: Among 41,254 TB patients registered for treatment at the 23 health centers, 2708 (6.6%) were children.
Among children with TB, the proportions of smear positive PTB, smear negative PTB and EPTB were 9.6%, 43.0%
and 47.4%, respectively. Treatment outcomes were documented for 95.2% of children of whom 85.5% were
successfully treated while rates of mortality and defaulting from treatment were 3.3% and 3.8%, respectively. The
proportion of children with TB tested for HIV reached 88.3% during the final year of the study period compared
to only 3.9% at the beginning of the study period. Mortality was significantly higher among under-five children
(p < 0.001) and those with HIV co-infection (p < 0.001). On multivariate logistic regression, children 5–9 years
[AOR = 2.50 (95% CI 1.67-3.74)] and 10–14 years [AOR = 2.70 (95% CI 1.86-3.91)] had a significantly higher successful
treatment outcomes. On the other hand, smear positive PTB [AOR = 0.44 (95% CI 0.27-0.73), HIV co-infection
(AOR = 0.49(95% CI 0.30-0.80)] and unknown HIV sero-status [AOR = 0.60 (95% CI 0.42-0.86)] were predictors of poor
treatment outcomes.
Conclusion: The proportion of childhood TB in this study is lower than the national estimate. The overall treatment
success rate has met the WHO target. Nonetheless, younger children (< 5 years), children with smear positive PTB
and those with HIV co-infection need special attention to reduce poor treatment outcomes among children in the
study area.
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Tuberculosis (TB) is one of the major public health prob-
lems worldwide. In 2012 alone, there were 8.6 million new
cases and 1.3 million deaths globally [1]. Although the true
burden of childhood TB is not well known, it is one of the
10 major causes of childhood mortality with estimated
annual deaths of 74,000 [1] to 130,000 [2]. Besides, it is* Correspondence: mulg2002@yahoo.com
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reproduction in any medium, provided the orestimated that about 6% of new cases of TB occur in chil-
dren [1,3]; however, this proportion varies with the preva-
lence of TB in adults ranging from ~5% in low-burden
countries to 20-40% in high-burden countries [2]. More
than 75% of children with TB are from the 22 high-burden
countries [2,4]. In Ethiopia, one of the 22 high TB burden
countries, TB is the second leading cause of death [5]. It is
estimated that children contribute to 16.1% of the national
TB burden [3]. In an effort to control the disease, the
country adopted the WHO DOTS strategy as a standard-
ized TB prevention and control programme in 1992.d. This is an Open Access article distributed under the terms of the Creative
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population; moreover, children are the primary victims
of a poor TB control programme [3]. The highest prior-
ity, however, has been given to infectious TB cases
(mostly of adults) and the management and prevention
of TB among children is relatively neglected despite the
fact that TB is a cause of significant childhood mortality
and morbidity [1,3]. In TB endemic countries, delayed
diagnosis and high case density are major factors con-
tributing to continued transmission [6]. In addition, epi-
demiological data on childhood TB is limited [4] mainly
because of absence of surveillance data as well as poor
ascertainment of cases [6].
In low income countries, children with respiratory in-
fections present with multiple infectious diseases includ-
ing TB [7] complicating diagnosis and proper treatment.
Because the routine diagnostic test for TB is smear mi-
croscopy, correct diagnosis of TB is difficult among the
majority of children especially the young since either
they do not produce sputum or have paucibacillary spu-
tum. Thus, diagnosis in these patients heavily depends
on clinical history (suggestive symptoms, poor response
to a course of antibiotics, contact to known PTB pa-
tients) and physical examination including growth as-
sessment and chest x-ray.
Surveillance data on childhood TB is important to de-
fine its epidemiology and identify predictors of poor
treatment outcomes. WHO recommends that children
with TB should be treated and notified through the na-
tional TB control programme [4]. However, like any
other resource-poor countries, such reports in Ethiopia
are mainly limited to adults with infectious TB patients.
In Ethiopia, apart from studies in rural areas [8,9], the
contribution of childhood TB as well as its treatment
outcomes is not well documented. This study, therefore,
investigated the treatment outcomes of TB and its pre-
dictors among children in an urban setting.
Methods
Study area
This study was conducted in Addis Ababa which is
home to about 2.7 million people [10]. Administratively,
the city is divided into 10 sub-cities and 116 Woredas
which are the lowest administrative units. The public
health institutions in the city include 10 hospitals & 26
health centers. In addition, there are 36 hospitals and
over 400 clinics run by the private sector. TB treatment
was limited to public health facilities mainly health cen-
ters until 2006 when some selected private health facil-
ities were included as pilot sites [11]. The Public-Private
Mix program has been progressively expanded since
then. By 2011, 9.5% of TB patients were detected at the
private health facilities nationwide [11]. The majority of
TB patients diagnosed at hospitals (both governmentand private owned) and private clinics were mainly re-
ferred to the nearest health centers for treatment. There-
fore, this study included 23 of the total 26 health centers
which were providing DOTS service during data collec-
tion; the remaining 3 health centers were excluded since
they started the service recently (< 1 year).
TB diagnosis and treatment in children
According to the Ethiopian National TB and Leprosy
Control Program (NTLCP) [5], patients having cough
lasting for at least 2 weeks should have smear micro-
scopic examination of their sputum. Clinical history,
chest x-ray, HIV testing and histopathology are used to
diagnosis smear negative pulmonary TB (PTB) and extra
pulmonary TB (EPTB). Among PTB suspects, clinical
diagnosis is made if two of these features are present:
positive contact history, suggestive physical signs, and
suggestive chest x-ray findings. Besides, chest x-ray with
miliary feature, bacteriological evidence (smear or cul-
ture positive) or histopathological evidence alone could
be taken as an evidence to diagnose TB. Treatment of
new TB patients consists of a 2-month intensive phase
followed by a 4-month continuation phase. During the
intensive phase, 4 drugs (Rifampicin, Isoniazid, Pyrazina-
mide and Ethambutol) are taken daily under the supervi-
sion of a health worker. In the continuation phase, two
drugs (Rifampicin and Isoniazid) are taken every day and
in this phase parents/caregivers are in charge of supervis-
ing adherence to treatment.
Study design and data collection
A retrospective data analysis was done on the treatment
outcomes of children (<15 years) with TB who were regis-
tered for treatment from January 2007 until December
2011 at health centers in Addis Ababa. Data on demo-
graphics (age and sex), types of TB, smear result (baseline
and follow-up for smear positive PTB patients), categories
of TB, HIV sero-status and treatment outcomes were
extracted from TB unit registers of each health center.
Standard definitions of the Ethiopian NTLCP guideline [5]
for categories, types of TB and treatment outcomes were
used. Data were extracted from TB unit registers of each




The sum of patients who were declared “cured” and “treat-
ment completed”.
Poor treatment outcome
Includes patients who were documented as “died”,
“defaulted”, “treatment failures” and “transferred out”.
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The data extracted from TB unit registers were checked
for completeness and accuracy. Data were entered into
excel and exported to SPSS version 20 for analysis. Chi-
square test was used for categorical variables to evaluate
associations between dependent and independent vari-
ables. Since age was not normally distributed, Mann–
Whitney test was used to analyze the association
between age and smear positivity among PTB patients.
Multivariate logistic regression was performed to iden-
tify predictors of treatment outcomes. The association of
predictor variables with the dependent variable was de-
scribed using 95% confidence interval (CI) and adjusted
odds ratio (aOR). A p-value < 0.05 was considered statis-
tically significant.
Ethical consideration
Ethical clearance was obtained from the Institutional Re-
view Board of Aklilu Lemma Institute of Pathobiology,
Addis Ababa University and Addis Ababa City Adminis-
tration Health Bureau. To maintain confidentiality,
names or other identifiers of study participants were not
included.
Results
Over 5 years, a total of 41,254 TB patients were regis-
tered for treatment at the selected health centers, of
whom 2708 (6.6%) were children. Overall, childhood TB
contributed to 2.4% of smear positive PTB, 7.6% of
smear negative PTB and 8.4% of EPTB patients. AmongFigure 1 Age distribution of children with TB in Addis Ababa, 2007–2children with TB, the median age was 9 (IQR 5–12)
years, and 52.7% of them were females. Nearly half of
children with TB were 10 years or older whereas those
younger than 5 years accounted for 23.7% (Figure 1).
The majority (88.1%) of children were registered as new
TB patients whereas 6.7% were transferred in from other
health facilities. Twenty-three (0.9%) children with TB
were registered as retreatment cases. EPTB accounted
for nearly half (47.4%) of childhood TB (Table 1).
Among children <5 years, the proportion of EPTB is
slightly lower (44.8%) compared to older children.
Among children diagnosed with PTB, only 18.2% were
smear positive. Smear positivity was significantly associ-
ated with HIV infection, age and sex of children. A signifi-
cantly higher proportion of HIV positives were diagnosed
with smear negative PTB compared to HIV negatives
(p < 0.001). The majority (80%) of smear positive PTB
patients were 10 years or older (median 13 yrs, IQR 10–
14 yrs) compared to children with smear negative PTB
(median 8 yrs, IQR 4–12 yrs) (Mann–Whitney, p <
0.001). A significantly higher proportion of females than
males had smear positive PTB (p < 0.001) (Table 2).
Of the total 259 children with smear positive PTB,
sputum smear microscopy was done for 207 (79.9%) at
the end of the second month of treatment and 6 (2.3%)
were documented as smear positive. At the end of the
5th month, 3/189 (1.2%) were smear positive and one
additional patient who was smear negative at the 5th
month became smear positive on completion of treat-
ment, making the number of children who failed to011.
Table 1 Treatment outcomes of children with TB in Addis Ababa, 2007-2011
Characteristics Successfully treated Poor treatment outcome
Cured (n = 169) Completed treatment
(n = 2024)
Died (n = 83) Failed (n = 6) Defaulted (n = 99) Transfer out (n = 184) p-value
Age
0–4 4(0.7) 461(77.1) 36(6.0) 1(0.2) 37(6.2) 59(9.9) <0.001
5–9 22(3.0) 626(86.0) 22(3.0) 0(0) 21(2.9) 37(5.1)
10-14 143(11.4) 947(75.7) 26(2.1) 5(0.4) 41(3.3) 89(7.1)
Sex
Male 59(4.9) 989(81.5) 37(3.0) 2(0.2) 45(3.7) 82(6.7) 0.02
Female 109(8.1) 1049(77.0) 47(3.4) 2(0.1) 53(3.9) 103(7.6)
Type of TB†
PTB + * 167(67.1) 37(14.9) 10(4.0) 4(1.6) 13(5.2) 18(7.2) <0.001
PTB-† NA* 944(85.4) 35(3.2) NA* 47(4.3) 79(7.1)
EPTB‡ NA* 1054(86.6) 37(3.0) NA* 38(3.1) 88(7.2)
Category
New 157(7.0) 1782(78.9) 65(2.9) 3(0.1) 90(4.0) 161(7.1) <0.001
Relapse 7(41.2) 9(52.9) 0(0) 0(0) 0(0) 1(5.9)
Treatment failure 0(0) 0(0) 0(0) 1(100) 0(0) 0(0)
Defaulter 0(0) 3(100) 0(0) 0(0) 0(0) 0(0)
Others 0(0) 94(83.9) 8(7.1) 0(0) 2(1.8) 8(7.1)
HIV
Negative 72(7.9) 729(80.2) 18(2.0) 2(0.2) 26(2.9) 62(6.8) <0.001
Positive 17(5.2) 260(79.8) 22(6.7) 2(0.6) 8(2.5) 17(5.2)
Unknown 79(5.9) 1044(78.2) 43(3.2) 0(0) 64(4.8) 105(7.9)
*NA = not applicable; *PTB + = Smear positive PTB; †PTB- = Smear negative PTB; ‡EPTB = Extra pulmonary TB.
†chi-square test was done after combining “cured” and “treatment completed”.
Table 2 Factors associated with types of TB among
children with TB in Addis Ababa
Characteristics PTB+ PTB- EPTB p-value
Sex
Male 91(7.1) 576(45.1) 611(47.8)
Female 168(11.8) 486(41.2) 667(46.9) <0.001
Age
0-4 11(1.7) 342(53.8) 286(44.8)
5-9 40(5.3) 359(47.7) 354(47.0) <0.001
10-15 208(15.9) 461(35.3) 638(48.8)
HIV infection
Negative 105(11.1) 377(39.9) 463(49.0)
Positive 28(8.1) 215(62.1) 103(29.8) <0.001
Unknown 125(8.9) 568(40.6) 707(50.5)
Category
New 236(10.0) 1023(43.2) 1109(46.8) 0.14
Others 23(6.9) 139(42.0) 169(51.1)
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65.3% of the smear positive PTB cases were reported to
be cured based on follow-up smear results.
The proportion of children with TB who were tested
for HIV progressively increased over the years. In 2007,
only 3.9% of the children with TB were tested for HIV;
however, HIV testing has increased to 62.7% and 88.3%
in 2009 and 2011, respectively. Overall, HIV status was
known for 47.9% of children and among these, 26.8%
were co-infected with the virus. Children younger than
10 years had a significantly higher proportion of HIV
co-infection (33.8%) compared to older children (19.8%)
(p < 0.001).
Among the 2708 children registered for treatment, 131
(4.9%) had no documented treatment outcomes. Of the
2579 children with documented treatment outcomes,
85.5% were successfully treated (Table 1). Although the
overall treatment success was high, there was a signifi-
cant variation across the health centers, from as low as
76% to as high as 96% (p = 0.002). Children younger
than 5 years had a treatment success of 78.1%, signifi-
cantly less than the treatment success among older chil-
dren (> = 87.3%) (p < 0.001). Similarly, treatment success
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positive PTB having a lower (81.9%) treatment success
compared to patients with either EPTB (86.6%) or smear
negative PTB patients (85.4%) (p = 0.15). On the other-
hand, treatment outcomes were similar among males
(86.3%) and females (85.0%) (p = 0.35). Similarly, there
was no significant difference in the overall treatment
success rate over the five years (84.4% to 86.7%).
Eighty-four (3.3%) and 99 (3.8%) of children registered
for treament were documented as dead and defaulted,
respectively. The default rate has dropped from 6.2% in
2006 to 3.8% in 2011, whereas mortality decreased from
4% in 2006 to 2% in 2010; however, the reduction in
poor outcomes over the years is not significantly differ-
ent (p for trend = 0.17) (Figure 2). Mortality was signifi-
cantly higher among HIV infected (6.7%) compared
to HIV negative children (2%) (p < 0.001). Moreover,
those younger than 5 years had a significantly higher
mortality (6%) and defaulting rate (6%) compared to
older children (mortality and defaulting rates of 2.4%
and 3.1%, respectively) (p < 0.001).
On multivariate logistic regression, age group 5–9 years
[AOR= 2.50 (95% CI 1.67-3.74)] and 10–14 years [AOR =
2.70 (95% CI 1.86-3.91)] were independently associated
with successful treatment outcomes. On the other hand,
patients with smear positive PTB [AOR= 0.44 (95% CI
0.27-0.73), those co-infected with HIV virus (AOR = 0.49
(95% CI 0.30-0.80)] and those with unknown sero-status
[AOR= 0.60 (95% CI 0.42-0.86)] had significantly lower
treatment success rates (Table 3).
Discussion
This study investigated the treatment outcomes of chil-
dren registered for TB treatment at health centers of
Addis Ababa. Children contributed to 6.6% of the total




















Figure 2 Trends of mortality, treatment defaulting, treatment failure
2007–2011.agreement with a previous study in 3 health centers of
Addis Ababa [12] but much lower than the proportion
reported in Southern Ethiopia [8,9] and the national esti-
mate (16.1%) [3]. Delayed diagnosis among adult TB pa-
tients has been reported to be a serious problem both in
rural [13,14] and urban [15] Ethiopia, and therefore, it is
likely that continued transmission with high childhood
TB exist in the country. Nonetheless, significant varia-
tions between communities are common without clear
explanations [16]. Misdiagnosis of childhood TB espe-
cially among the young is a common problem in TB en-
demic countries [6] which might have contributed to a
relatively low proportion of childhood TB in our study.
This is substantiated by the fact that under-five children
represented only a small proportion of children with TB
in our study although the young are said to be more vul-
nerable to disease progression [3].
The risk of progression to active TB is greatest among
young children especially those below 2 years [17] and
under-five children constituted the majority of childhood
TB in previous studies in Africa [18,19] and Thailand
[20]. However, in our study, older children (10–14 years)
represented nearly half (48.4%) of the registered cases.
Although not evident from the current study, it is prob-
able that TB among young children might have been
missed.
The majority (81.7%) of children with PTB were smear
negative which is in agreement with previous reports
[8,21]. This is mainly because most children present with
primary rather than secondary TB (with cavitory lesions)
and therefore, are likely to have low bacillary load.
Moreover, young children do not produce sputum for
smear microscopy and are diagnosed based on clinical
and chest x-ray evidences. The proportion of children
with EPTB (47.4%) in this study is comparable to a re-





and transfer out among children with TB in Addis Ababa,
Table 3 Predictors of successful treatment outcomes among children with TB, Addis Ababa
Characteristics Successfully treated* Not successfully treated AOR (95% CI)
Frequency (%) Frequency (%)
Age
0-4 466(86.6) 72(13.4) 1.00
5-9 648(93.8) 43(6.2) 2.50(1.67-3.74)
10-14 1093(94.0) 70(6.0) 2.70(1.86-3.91)
Type of TB
PTB- 944(92.0) 82(8.0) 1.00
PTB+ 204(88.3) 27(11.7) 0.44(0.27-0.73)
EPTB 1054(93.4) 75(6.6) 1.09(0.78-1.52)
HIV infection
Negative 801(94.6) 46(5.4) 1.00
Positive 277(89.6) 32(10.4) 0.49(0.30-0.80)
Unknown 1123(91.3) 107(8.7) 0.60(0.42-0.86)
*Transferred out patients were excluded from the Logistic Regression Model since their treatment outcome is unknown. The model was adjusted for sex.
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our study is much higher compared to two recent re-
ports from Southern Ethiopia (24.8%) [6] and (31.1%) [7]
and Malawi [18]. The relatively low TB burden together
with a high proportion of EPTB among children in our
study suggests that further epidemiological study on
childhood TB is important.
Regarding treatment outcomes, the overall treatment
success rate of 85.5% has met the WHO target. The
treatment success rate in this study is higher compared
to previous reports both from Ethiopia [8,9] and else-
where in Africa [19,21,22]. This difference might be re-
lated to differences in setting, disease presentation as
well as prevalence of HIV infection. Besides, there might
be differences in the level of adherence which is mainly
dependent on the parents’ level of supervision and
administration of medication especially among young
children.
The mortality rate (3.3%) in this study is comparable
to the mortality rate (3.7%) reported for both adults and
children in Addis Ababa [12] but is lower compared to
previous reports from other parts of Ethiopia (5.8% and
5.3%) [8,9], Botswana (10.5%) [22], Tanzania (10.9%) [21]
and Malawi (17%) [19]. In this study, the majority of
children were tested for HIV in the later years of the
study period, which might have partly contributed to
better management of TB and other HIV related infec-
tions thereby reducing mortality. Alternatively, the lack
of data on the treatment outcomes of transferred out
and defaulted children among whom mortality is ex-
pected to be higher might have resulted in underestimat-
ing the mortality rate.
A number of factors associated with treatment out-
comes have been reported. In this study, smear positive
PTB was found to be associated with poor treatmentoutcome as previously reported [23]. In contrast to our
finding, however, some studies [8,19] reported that hav-
ing smear positive PTB is associated with favorable treat-
ment outcomes. However, it might be reasonable to
assume that children with smear positive PTB to have
advanced disease at presentation, resulting in poor treat-
ment outcomes.
The treatment success rate among children younger
than 5 years was low with a significantly higher mortality
and defaulting rates. In agreement with this finding, a
study in Malawi [19] reported a decline in the death and
defaulting rates with advanced age. Younger children es-
pecially those under two years are at a greater risk of
death from infectious diseases including TB because of
immature immune systems. Moreover, disseminated TB
and TB meningitis, both associated with high mortality,
are more common among young children [2,3,24]. Diag-
nosis of TB in younger children remains a challenge and
most end up with anti-TB treatment without confirm-
ation. This would lead to delay in the diagnosis and
treatment of other serious illnesses especially HIV-
related opportunistic infections resulting in increased
mortality.
The proportion of children tested for HIV progres-
sively increased over the years, from 3.9% in 2007 to
88.1% by the end of the study period. Introduction of
provider-initiated counseling and testing has probably
resulted in a recent increase in the proportion of those
tested for the virus. Among tested, TB-HIV co-infection
was found to be 26.8%. However, the co-infection rate
considerably varied with age, older children having the
least co-infection rate. Knowledge of HIV sero-status is
essential for better management of TB as well as HIV/
AIDS. In this study, co-infection with HIV was found to
be an independent predictor of unfavorable treatment
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ment with previous reports elsewhere [21,22,25]. HIV
co-infection is commonly associated with multiple infec-
tions complicating diagnosis as well as treatment [7] and
hence leading to greater morbidity and mortality.
This study is not without limitations and therefore, the
findings of this study should be interpreted in view of
the following limitations. First, socioeconomic data in-
cluding family income and educational status of parents
which might influence treatment outcomes were not
documented and therefore, the role of such variables
was not investigated. In addition, not all health facilities
providing DOTS were included in this study, which
might limit the generalizability of our findings to all chil-
dren with TB registered for treatment in Addis Ababa.
Conclusions
The proportion of childhood TB in the study area is
lower than expected given the high prevalence of smear
positive TB in adults as well as the HIV epidemic. Inves-
tigating the diagnostic procedures at health facilities is
important to have an insight on the burden of childhood
TB. The overall treatment success rate in the current
study has met the WHO target of 85% and is higher
compared to previous reports from Ethiopia and Africa.
However, the outcomes of treatment varied with age,
HIV status and clinical forms of TB. Young children,
those co-infected with HIV and those with smear posi-
tive PTB need special attention to reduce unfavorable
treatment outcomes among children.
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